New research offers hope for improving the lives of those living with inflammatory bowel disease (IBD), including ulcerative colitis and…
Browsing: Clinical Updates
Researchers have developed a promising microbiome-based diagnostic test for inflammatory bowel disease (IBD), leveraging metagenomic data from nearly 6,000 fecal…
New research presented at DDW 2024 reveals that combining cognitive behavioral therapy (CBT) with mindfulness techniques significantly improves the mental…
The FDA has approved ustekinumab-aauz (Otulfi), a biosimilar to Stelara by Johnson & Johnson, for treating conditions like Crohn’s disease,…
A new study suggests that patients taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound may have inadequate bowel or…
The FDA has granted breakthrough therapy designation to Sagimet Biosciences’ denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) with…
The American Gastroenterological Association’s new guideline on Barrett’s esophagus focuses on updates for endoscopic eradication therapy (EET). Key highlights include…
At the ICG19·MH and MOHA Consortium, experts emphasized the growing potential of stool-based tests like COLOTECT for colorectal cancer (CRC)…
Researchers are uncovering the profound role of the gut microbiome in influencing numerous diseases, including cardiovascular disease, diabetes, and obesity.…
Merck’s combination of Keytruda and an anti-LAG-3 antibody failed to improve overall survival in metastatic microsatellite stable (MSS) colorectal cancer,…